Print

RV 144

Trial Details:

III Completed
DoD, Thailand MOPH, NIAID, TAVEG, Sanofi, VaxGen October 02, 2003
ALVAC-HIV vCP1521,AIDSVAX gp120 B/E Canarypox Env B,E; gp120 B/E
ALVAC-HIV vCP1521 Viral Vector - Pox
AIDSVAX gp120 B/E Protein
Thailand 16,403
NCT00223080
https://clinicaltrials.gov/ct2/show/NCT00223080